Previous 10 | Next 10 |
VANCOUVER and MINNEAPOLIS, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc , Inc. ("Neovasc" or the "Company") ( NASDAQ , TSX : NVCN) today announced that the journal EuroIntervention has published an article entitled, “Coronary Sinus Reducer Im...
Neovasc shares fall ([[NVCN]] -9.8%) after announcing that its Tiara Transapical system will be unable to receive a European CE mark under the current Medical Device Directive regulations.The company has been working with its Notified Body for more than a year to obtain a decision on a C...
VANCOUVER and MINNEAPOLIS, April 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") ( NASDAQ , TSX : NVCN), today announced that the Tiara Transapical system (“Tiara TA”) will be unable to receive a Europe...
Neovasc (TSX:NVCN) (NASDAQ:NVCN) is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular marketplace. The company’s products include Neovasc Reducer, for the treatment of refractory angina, which is no...
Are These Penny Stocks On Your “Buy” Or “Avoid” List This Week? We’re at the start of a brand new week and a whole new list of penny stocks to watch. One of the popular places that retail traders are searching is on Reddit. The social media discuss...
Neovasc, Inc. (NVCN) Q4 2020 Earnings Conference Call March 11, 2021 4:30 PM ET Company Participants Mike Cavanaugh - Managing Director at Westwicke Fred Colen - President and Chief Executive Officer Chris Clark - Chief Financial Officer Presentation Operator Greetings, and welcome to the Neo...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - March 11, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), today reported financial results for the fourth quarter and fiscal year ended December 31, 2020. Fourth Quarter Highlights ...
VANCOUVER and MINNEAPOLIS, March 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ( NASDAQ , TSX : NVCN) will report results for the fourth quarter and fiscal year ended December 31, 2020 after the market close on Thursday, March 11, 2021. Neovasc Pre...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - March 3, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), today announced that company management will be participating in the 2021 H.C. Wainwright Global Life Sciences Conference that is scheduled to take p...
VANCOUVER and MINNEAPOLIS, March 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc , Inc. ("Neovasc" or the "Company") ( NASDAQ , TSX : NVCN) today announced that the journal Clinical Cardiology has published an article entitled, “Long-term outcomes of pati...
News, Short Squeeze, Breakout and More Instantly...
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...